Frélii, Inc. announced that it expects to receive $0.125 million in funding from Current Capital Corp.
June 20, 2018
Share
Frélii, Inc.(OTCPK:FRLI) announced that it has entered into a subscription agreement with Current Capital Corp. for the issuance of an aggregate of 100,000 shares of restricted common stock at a price of $1.25 per share for the gross proceeds of $125,000 on June 20, 2018. The company will also issue warrant to purchase up to an additional 100,000 shares of common stock at $1.50 per share.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.